In Malawi urban areas have more unimmunised zero-dose children than rural regions. The government is working hard to close the immunisation gap.
Although it’s not clear how this compares to the full dose licensed worldwide for emergency use, a quarter of a dose produces an equivalent immune response to immunity from infection.
Launch of vaccine trial marks “significant milestone” towards beating this debilitating disease.
A study looking at health issues such as stroke or seizures after COVID-19 vaccination showed that vaccines weren’t linked to any significant number of side effects.
Gavi has supported a major expansion in yellow fever diagnostic capacity in Africa over the past three years. The results show just how much improving diagnostics can have a cost-effective yet significant impact on immunisation programmes.
Getting COVID-19 vaccines out to countries isn’t just about ensuring supply – a major stumbling block can be their ‘absorptive capacity,’ or the ability to deliver the volume of vaccine coming their way. Here, we talk to Alex de Jonquieres, Director of Health Systems & Immunisation Strengthening at Gavi, about supporting countries in delivering their doses.
A new study from Israel suggests the risk of a breakthrough infection among vaccinated people was higher than among people who’d previously had COVID-19 but had not been vaccinated. However the greatest benefit came to those who'd previously recovered from COVID-19 and received a vaccine dose.
A universal vaccine has been described as the ‘holy grail’ – but how close are we to getting one?
With evidence showing the COVID virus is airborne, it's no coincidence many outbreaks in schools have occurred in winter – when windows are closed.
A new study suggests the RTS,S malaria vaccine alone is as effective as preventive antimalarials; together they could save thousands of lives.